Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Univec Conglomerate Inc (UNVC) Message Board

Think How Big UNVC Will Become: Over 600 Lawsuits

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 87012
(Total Views: 251)
Posted On: 05/01/2019 7:48:53 PM
Avatar
Posted By: toodles
Think How Big UNVC Will Become: Over 600 Lawsuits Against Opioid Companies Become One Federal Court Case...Real Good Reads Here. Fox News Had A segment on it out of Fla. tonight
.

https://www.workingpartners.com/over-600-laws...ourt-case/

13 recent lawsuits involving pharma companies, PBMs, distributors
Below are 13 legal actions involving the drug supply chain, including pharmaceutical companies, PBMs and distributors, reported by Becker's Hospital Review in the last month.
1. Biotech accuses Dr. Soon-Shiong of orchestrating a 'catch and kill' scheme to protect cancer drug
A California biotech claims that controversial billionaire biotech entrepreneur Patrick Soon-Shiong, MD, orchestrated a "catch and kill" scheme to stop development of an experimental cancer drug that may have saved the U.S. healthcare system more than $1 billion.
2. Novartis must face trial over alleged physician kickbacks, judge rules
A federal judge in New York has ruled that Novartis must face trial in a case accusing the drugmaker of paying millions of dollars in kickbacks to physicians to boost prescription rates.
3. Class-action suit against Mylan over EpiPen will go forward, judge rules
Mylan must face a class-action lawsuit over its lifesaving allergy treatment EpiPen, a judge ruled March 29.
4. New York sues 6 opioid manufacturers, 4 distributors, the Sacklers
The New York attorney general is suing six opioid manufacturers, the Sackler family and four prescription drug distributors in a massive legal fight against the pharma industry accused of fueling the opioid crisis.
5. J&J cleared of liability in New Jersey talc case
In the latest talc trial, a New Jersey jury decided Johnson & Johnson was not liable for causing a man's mesothelioma.
6. 3 drugmakers settle lawsuit claiming they stifled generic competition
Three generic drugmakers — Teva Pharmaceuticals, Mylan and Ranbaxy — will pay $65.9 million to settle claims that they engaged in a scheme promoting anticompetitive behavior.
7. Purdue Pharma to pay $270M to settle Oklahoma opioid lawsuit
OxyContin maker Purdue Pharma and the billionaire Sackler family will pay $270 million to resolve Oklahoma's claims that the company helped fuel the opioid epidemic.
8. Dr. Reddy's legal win expected to lower cost of opioid addiction treatment
After a two-year legal battle, Dr. Reddy's Laboratories has won the right to sell a cheaper version of a best-selling opioid addiction treatment in the U.S.
9. Roche sues US execs, says diabetes test strips fraudulently resold
Roche has sued more than a dozen former executives at Alliance Medical Holdings over what the drugmaker calls fraudulent schemes involving its diabetes test strips.
10. Ohio sues OptumRx to recover $16M in alleged overcharges
Ohio Attorney General Dave Yost is suing pharmacy benefit manager OptumRx to recoup $16 million in alleged overcharges.
11. Judge tosses suit alleging Express Scripts 'stole' patients
A federal judge dismissed a lawsuit filed by six pharmacies that claimed Express Scripts violated health privacy laws and poached customers.
12. J&J hit with $29M verdict in California talc case
A California jury ordered Johnson & Johnson to pay $29 million to a woman who alleged that asbestos in the company's talc-based baby powder caused her fatal cancer.
13. Novartis to pay $23M to settle claims it used charity payments as kickbacks
Pharma giant Novartis agreed to pay $23 million to settle allegations that it used charities to pay kickbacks to Medicare patients to cover their out-of-pocket costs.


(4)
(0)




Univec Conglomerate Inc (UNVC) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us